Trading Day Triumph: Regulus Therapeutics Inc (RGLS) Ends at 1.00, a 0.00 Surge/Plunge

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.62 million shares were traded. RGLS stock price reached its highest trading level at $1.14 during the session, while it also had its lowest trading level at $0.93.

Ratios:

For a better understanding of RGLS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.65 and its Current Ratio is at 13.65. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on August 02, 2024, initiated with a Outperform rating and assigned the stock a target price of $7.

On March 18, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $6.

On March 28, 2018, B. Riley FBR Inc. started tracking the stock assigning a Neutral rating and target price of $1.B. Riley FBR Inc. initiated its Neutral rating on March 28, 2018, with a $1 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 30 ’25 when Hagan Joseph P bought 50,000 shares for $1.09 per share. The transaction valued at 54,260 led to the insider holds 260,808 shares of the business.

BALTIMORE DAVID bought 19,610 shares of RGLS for $20,787 on Jan 30 ’25. The Director now owns 22,169 shares after completing the transaction at $1.06 per share. On Jan 13 ’25, another insider, Aker Christopher Ray, who serves as the Sr. VP & General Counsel of the company, sold 38,547 shares for $1.26 each. As a result, the insider received 48,693 and left with 54,634 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RGLS now has a Market Capitalization of 65500100 and an Enterprise Value of -20563866.

Stock Price History:

The Beta on a monthly basis for RGLS is 1.57, which has changed by -0.25373137 over the last 52 weeks, in comparison to a change of 0.22208416 over the same period for the S&P500. Over the past 52 weeks, RGLS has reached a high of $3.79, while it has fallen to a 52-week low of $0.83. The 50-Day Moving Average of the stock is -30.94%, while the 200-Day Moving Average is calculated to be -42.29%.

Shares Statistics:

Over the past 3-months, RGLS traded about 397.57K shares per day on average, while over the past 10 days, RGLS traded about 820660 shares per day. A total of 65.50M shares are outstanding, with a floating share count of 52.66M. Insiders hold about 19.61% of the company’s shares, while institutions hold 69.93% stake in the company. Shares short for RGLS as of 1736899200 were 1760351 with a Short Ratio of 4.43, compared to 1734048000 on 1622956. Therefore, it implies a Short% of Shares Outstanding of 1760351 and a Short% of Float of 3.42.

Most Popular